{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:10:39Z","timestamp":1780416639538,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.msard.2026.107047","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:18:07Z","timestamp":1770016687000},"page":"107047","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multiple sclerosis and uveitis: Clinical characteristics and prognosis"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3380-3422","authenticated-orcid":false,"given":"William","family":"GIL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"CHACUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"ANDRODIAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"VASSENEIX","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"KODJIKIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"VUKUSIC","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"S\u00c8VE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"EL-JAMMAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107047_bib0001","doi-asserted-by":"crossref","first-page":"e909","DOI":"10.1212\/NXI.0000000000000909","article-title":"Intermediate uveitis associated with MS: diagnosis, clinical features, pathogenic mechanisms, and recommendations for management","volume":"8","author":"Abraham","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107047_bib0002","doi-asserted-by":"crossref","first-page":"e2545","DOI":"10.1212\/WNL.0000000000009491","article-title":"Distinguishing neurosarcoidosis from multiple sclerosis based on CSF analysis","volume":"94","author":"Arun","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107047_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102351","article-title":"Uveitis: autoimmunity\u2026 and beyond","volume":"18","author":"Bertrand","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2026.107047_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.52.1.179","article-title":"Multiple sclerosis associated with uveitis in two large clinic-based series","volume":"52","author":"Biousse","year":"1999","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107047_bib0005","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/aos.14697","article-title":"Insights into multiple sclerosis-associated uveitis: a scoping review","volume":"99","author":"Casselman","year":"2021","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"10.1016\/j.msard.2026.107047_bib0006","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajo.2021.03.044","volume":"228","year":"2021","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107047_bib0007","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/09273948.2017.1334469","article-title":"Multiple sclerosis-associated uveitis","volume":"25","author":"Cunningham","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.msard.2026.107047_bib0008","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/jcm12093194","article-title":"Sarcoidosis-related uveitis: a review","volume":"12","author":"Giorgiutti","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.msard.2026.107047_bib0009","first-page":"1","article-title":"Uveitis in the setting of Co-existing systemic sarcoidosis and multiple sclerosis","volume":"0","author":"Gnanaraj","year":"2023","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.msard.2026.107047_bib0010","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.msard.2014.09.017","article-title":"MS in Maghrebian inhabitants and immigrants","volume":"3","author":"Gouider","year":"2014","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107047_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104264","article-title":"Multiple sclerosis in Middle East North Africa (MENA) region: challenges, achievements and opportunities","volume":"71","author":"Hassan","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107047_bib0012","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of Multiple sclerosis: a review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.msard.2026.107047_bib0013","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/09273948.2016.1178302","article-title":"Mycophenolate Mofetil for the treatment of multiple sclerosis-associated uveitis","volume":"25","author":"Hedayatfar","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.msard.2026.107047_bib0014","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000431042","article-title":"Multiple Sclerosis Epidemiology in Middle East and North Africa: a systematic review and meta-analysis","volume":"44","author":"Heydarpour","year":"2015","journal-title":"Neuroepidemiology."},{"key":"10.1016\/j.msard.2026.107047_bib0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jaut.2015.06.010","article-title":"The immunogenetics of Multiple sclerosis: a comprehensive review","volume":"64","author":"Hollenbach","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.msard.2026.107047_bib0016","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/09273948.2015.1125508","article-title":"Multiple sclerosis-related uveitis: does MS treatment affect uveitis course?","volume":"25","author":"Jouve","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.msard.2026.107047_bib0017","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000341735","article-title":"Pattern of uveitis in an Egyptian population with multiple sclerosis: a hospital-based study","volume":"49","author":"Karara","year":"2013","journal-title":"Ophthalmic. Res."},{"key":"10.1016\/j.msard.2026.107047_bib0018","first-page":"1010","article-title":"Uveitis associated with multiple sclerosis: complications and visual prognosis","volume":"7","author":"Kaya","year":"2014","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107047_bib0019","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2010.4151.x","article-title":"Epidemiology of uveitis in the Middle East and North Africa","volume":"88","author":"Khairallah","year":"2010","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"10.1016\/j.msard.2026.107047_bib0020","first-page":"33","article-title":"Pattern of uveitis in a referral centre in Tunisia","volume":"21","author":"Khairallah","year":"2007","journal-title":"North Africa. Eye"},{"key":"10.1016\/j.msard.2026.107047_bib0021","article-title":"Multiple sclerosis in the Middle East and North Africa region","volume":"6","author":"Khoury","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107047_bib0022","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107047_bib0023","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1352458507083444","article-title":"Uveitis associated with multiple sclerosis","volume":"14","author":"Le Scanff","year":"2008","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107047_bib0024","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ophtha.2018.10.013","article-title":"Uveitis in patients with multiple sclerosis in clinical trials of Fingolimod: incidence, prevalence, and impact on disease course","volume":"126","author":"Lim","year":"2019","journal-title":"Ophthalmology."},{"key":"10.1016\/j.msard.2026.107047_bib0025","article-title":"Multiple sclerosis and human leukocyte antigen genotypes: focus on the Middle East and North Africa region","volume":"6","author":"Maghbooli","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107047_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105095","article-title":"Prognosis of patients with multiple sclerosis associated with uveitis","volume":"80","author":"Martin","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107047_bib0027","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","article-title":"Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis","volume":"103","author":"Mochizuki","year":"2019","journal-title":"British Journal of Ophthalmology"},{"key":"10.1016\/j.msard.2026.107047_bib0028","article-title":"Sarcoidosis: pitfalls and challenging mimickers","volume":"7","author":"Narula","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.msard.2026.107047_bib0029","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/WNO.0000000000000507","article-title":"Ocular motor manifestations of multiple sclerosis","volume":"37","author":"Nerrant","year":"2017","journal-title":"J. Neuro-Ophthalmol."},{"key":"10.1016\/j.msard.2026.107047_bib0030","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.survophthal.2016.07.002","article-title":"The association between multiple sclerosis and uveitis","volume":"62","author":"Olsen","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.msard.2026.107047_bib0031","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.patbio.2013.05.002","article-title":"Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II","volume":"61","author":"Ouadghiri","year":"2013","journal-title":"Pathologie Biologie"},{"key":"10.1016\/j.msard.2026.107047_bib0032","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0264918","article-title":"Uveitis prior to clinical presentation of Multiple Sclerosis (MS) is associated with better MS prognosis","volume":"17","author":"Raskin","year":"2022","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107047_bib0033","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1474-7766.2004.06-228.x","article-title":"Visual and eye movement problems in multiple sclerosis","volume":"4","author":"Rucker","year":"2004","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.msard.2026.107047_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307455","article-title":"Uveitis characteristics and multiple sclerosis phenotype of patients with multiple sclerosis-associated uveitis: a systematic review and meta-analysis","volume":"19","author":"Saboya-Galindo","year":"2024","journal-title":"PLoS. One"},{"key":"10.1016\/j.msard.2026.107047_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00520-2","article-title":"Patients with Multiple Sclerosis and concomitant uveitis\/periphlebitis retinae are not distinct from those without intraocular inflammation","volume":"187","author":"Schmidt","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107047_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00984","article-title":"Human leukocyte antigen (HLA)-DRB1\u00d715:01 and HLA-DRB5\u00d701:01 present complementary peptide repertoires","volume":"8","author":"Scholz","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107047_bib0037","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1352458514539782","article-title":"Uveitis as a prognostic factor in multiple sclerosis","volume":"21","author":"Shugaiv","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107047_bib0038","doi-asserted-by":"crossref","unstructured":"Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop, 2005. . American Journal of Ophthalmology 140, 509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057.","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"10.1016\/j.msard.2026.107047_bib0039","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107047_bib0040","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/372361","article-title":"Ipsilateral uveitis and optic neuritis in multiple sclerosis","author":"Thouvenot","year":"2012","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.msard.2026.107047_bib0041","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1212\/CPJ.0000000000000629","article-title":"Multiple sclerosis and sarcoidosis","volume":"9","author":"Tyshkov","year":"2019","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2026.107047_bib0042","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1474-4422(18)30443-5","article-title":"Global, regional, and national burden of multiple sclerosis 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Wallin","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107047_bib0043","article-title":"Epidemiology and phenotypes of multiple sclerosis in the Middle East North Africa (MENA) region","volume":"6","author":"Yamout","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107047_bib0044","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273940490895344","article-title":"Multiple sclerosis-associated uveitis","volume":"12","author":"Zein","year":"2004","journal-title":"Ocul. Immunol. Inflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T15:49:36Z","timestamp":1780415376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":44,"alternative-id":["S2211034826000830"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107047","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple sclerosis and uveitis: Clinical characteristics and prognosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107047"}}